DBT
ALXN

Dubuque Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Dubuque Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,323
Closed -$243K – 288
2021
Q2 		$243K Sell
1,323
-90
-6% -$15.4K 0.03% 231
2021
Q1 		$216K Hold
1,413
– – 0.02% 247
2020
Q4 		$221K Buy
+1,413
New +$182K 0.03% 235
2019
Q2 		– Sell
-50
Closed -$7K – 664
2019
Q1 		$7K Buy
+50
New +$6.22K ﹤0.01% 538
2017
Q2 		– Sell
-138
Closed -$17K – 673
2017
Q1 		$17K Hold
138
– – ﹤0.01% 442
2016
Q4 		$17K Hold
138
– – ﹤0.01% 363
2016
Q3 		$17K Buy
138
+59
+75% +$7.59K ﹤0.01% 342
2016
Q2 		$9K Sell
79
-59
-43% -$8.37K ﹤0.01% 447
2016
Q1 		$19K Buy
138
+46
+50% +$6.75K ﹤0.01% 349
2015
Q4 		$18K Buy
+92
New +$16.1K ﹤0.01% 410

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return